ArmonAir Digihaler Interactions
There are 103 drugs known to interact with ArmonAir Digihaler (fluticasone), along with 6 disease interactions. Of the total drug interactions, 36 are major, 52 are moderate, and 15 are minor.
- View all 103 medications that may interact with ArmonAir Digihaler
- View ArmonAir Digihaler disease interactions (6)
Most frequently checked interactions
View interaction reports for ArmonAir Digihaler (fluticasone) and the medicines listed below.
- Advil (ibuprofen)
- Afrin (oxymetazoline nasal)
- albuterol
- Align (bifidobacterium infantis)
- Alvesco (ciclesonide)
- Aquoral (saliva substitutes topical)
- azelastine nasal
- Breztri Aerosphere (budesonide / formoterol / glycopyrrolate)
- BuSpar (buspirone)
- buspirone
- Calcium 600 D (calcium / vitamin d)
- calcium / vitamin d
- cholestyramine
- chondroitin / glucosamine
- clobetasol topical
- CoQ10 (ubiquinone)
- cyclobenzaprine
- Cymbalta (duloxetine)
- Diflucan (fluconazole)
- Dulera (formoterol / mometasone)
- Effexor XR (venlafaxine)
- epinephrine
- fluocinonide topical
- gabapentin
- Horizant (gabapentin enacarbil)
- hyoscyamine
- l-methylfolate
- Lamictal XR (lamotrigine)
- levothyroxine
- Wellbutrin XL (bupropion)
ArmonAir Digihaler disease interactions
There are 6 disease interactions with ArmonAir Digihaler (fluticasone) which include:
- hepatic impairment
- hyperadrenocorticism
- infections
- ocular herpes simplex
- ocular toxicities
- osteoporosis
More about ArmonAir Digihaler (fluticasone)
- ArmonAir Digihaler consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: inhaled corticosteroids
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.